Switzerland: A recent study published in JAMA Cardiology suggests that women with high bleeding risk (HBR) did not experience higher rates of bleeding or ischemic compared with men and may derive.
Greece: The very short duration of dual antiplatelet therapy (VSDAPT) of less than three months could be feasible and well tolerated after PCI (percutaneous coronary intervention) with DES.
Dual Antiplatelet Therapy Market has been evolving and changing over the course of past few decades and the market scope has changed a lot over the course of time and to better understand the market’s current landscape this report on Dual Antiplatelet Therapy market will be of great importance. The report has a deta.
Market OverviewDual antiplatelet therapy is defined as the use of aspirin and P2Y12 receptor inhibitor to prevent blood clotting, and through a double mechanism, it prevents thrombotic complications.The dual antiplatelet therapy is often prescribed for patients who had a cardiac attack, had coronary artery bypass gr.